Claims for Patent: 4,904,650
✉ Email this page to a colleague
Summary for Patent: 4,904,650
Title: | Substituted androsta-1,4-diene-3,17-diones |
Abstract: | The invention relates to 6-alkylidenadrosta-1,4-diene-3,17-dione derivatives, having the following general formula ##STR1## wherein each of R and R.sub.2, independently, is hydrogen or C.sub.1 -C.sub.6 alkyl and R.sub.1 is hydrogen, halogen or C.sub.1 -C.sub.6 alkyl, which are useful in therapy, in particular in the treatment of hormone-dependent cancers. |
Inventor(s): | Buzzetti; Franco (Monza, IT), Barbugian; Natale (Milan, IT), Lombardi; Paolo (Milan, IT), di Salle; Enrico (Milan, IT) |
Assignee: | Farmitalia Carlo Erba S.p.A. (Milan, IT) |
Application Number: | 07/225,674 |
Patent Claims: |
1. A compound of general formula (I) ##STR10## wherein each of R and R.sub.2, independently, is hydrogen or C.sub.1 -C.sub.6 alkyl and R.sub.1 is hydrogen, halogen or C.sub.1 -C.sub.6
alkyl.
2. A compound of formula (I), according to claim 1, wherein R is hydrogen or C.sub.1 -C.sub.4 alkyl; R.sub.1 is hydrogen, fluorine, chlorine or C.sub.1 -C.sub.4 alkyl; and R.sub.2 is hydrogen or C.sub.1 -C.sub.4 alkyl. 3. A compound of formula (I), according to claim 1, wherein R is hydrogen, methyl or ethyl; R.sub.1 is hydrogen, fluorine or chlorine and R.sub.2 is hydrogen. 4. A pharmaceutical composition containing a suitable carrier and/or diluent and, as an active principle, a therapeutically effective amount of a compound of claim 1, or a pharmaceutically acceptable salt thereof. 5. A pharmaceutical composition, suitable for the treatment of advanced hormone-dependent breast, pancreatic, endometrial or ovarian cancers, comprising, as an active principle, a therapeutically effective amount of a compound of claim 1, in association with a suitable carrier and/or diluent. 6. A pharmaceutical composition, suitable for the treatment of prostatic hypertrophy or prostatic hyperplasia, comprising, as an active principle, a therapeutically effective amount of a compound of claim 1, in association with a suitable carrier and/or diluent. 7. A method for the treatment of advanced hormone-dependent breast, pancreatic, endometrial or ovarian cancer comprising administering patients in need of such treatment an effective amount of a compound of claim 1. 8. A method for the treatment of prostatic hypertrophy or prostatic hyperplasia comprising administering to patients in need of such treatment an effective amount of a compound of claim 1. |